|
|
 |
|
Viewing report
|
|
 |
 |
Pricing Strategies for Medical Device and Diagnostic Companies
HBS Consulting, May 2006
Pricing strategies need to balance the demands of the market, i.e. what the customer needs and wants, with the needs of the company. Pricing objectives need to be closely linked with organizational and marketing objectives, as well as taking account of cash-flow requirements, profit objectives and return on investment (ROI). In addition, they must take into account the market’s price sensitivity, which is defined as the relative importance of price in a purchasing decision. In view of the complexities involved in pricing obtaining an efficient pricing strategy is an important issue for all medical device and diagnostic companies.
This latest strategic publication ' Pricing Strategies for Medical Device and Diagnostic Companies” provides:
- An analysis of the benefits and advantages various pricing strategies can offer - Provides a detailed insight into impacting factors affecting pricing strategies in Europe, US and Japan - Case studies reviewing experiences of companies within the medical device and diagnostic sectors
Pricing is a strategy that should be understood by all the members of a company and this report is relevant to all medical device company employees. However, its specific target is the CEO’s, pricing managers, marketing and sales personnel of medical device companies who should be working together to develop their companies’ pricing strategy.
Product samples
Executive Summary - Medical Device and Diagnostic Companies
Customers who bought this item also bought
Mobile Pricing Innovations - The price of pricing
Outcomes-Based Pharmaceutical Pricing
Strategies for Mobile Broadband Pricing and Packaging
Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world�s second largest market
Pharmaceutical Pricing and Reimbursement in the United States, 2008
HIV Pricing Strategies in the US and UK
Pharmaceutical Pricing Strategies: Price optimization, reimbursement and regulation in Europe, US and Japan
The Challenges of Reference Pricing in Europe
Pricing Strategies In The UK Personal Loan Market 2007
U.S. Pharma Pricing Strategies: Case Studies and Future Considerations
Pharmaceutical Pricing and Reimbursement: Strategies for Market Access Across the US, Europe, Japan and Other Key Geographies
Pharmaceutical Pricing and Reimbursement in Japan, 2008
|
 |
|
|